[Baboon syndrome].
Sánchez-Morillas L, Reaño Martos M, Rodríguez Mosquera M, Iglesias Cadarso C, González Sánchez L, Domínguez Lázaro AR.
Allergol Immunopathol (Madr). 2004 Jan-Feb;32(1):43-5. doi: 10.1016/s0301-0546(04)79223-x.
[Drug allergy].
Yamaguchi M.
Arerugi. 2012 Jun;61(6):753-9.
Reaction to intravenous aminophylline.
Davidson MB.
N Engl J Med. 1971 Sep 16;285(12):689. doi: 10.1056/nejm197109162851214.
Hypersensitivity myocarditis.
Burke AP, Saenger J, Mullick F, Virmani R.
Arch Pathol Lab Med. 1991 Aug;115(8):764-9.
Immediate adverse reaction to aminophylline.
de la Hoz B, Pérez C, Tejedor MA, Lázaro M, Salazar F, Cuevas M.
Ann Allergy. 1993 Nov;71(5):452-4.
The efficacy of topical aminophylline in local fat reduction: A systematic review.
Abdi Dezfouli R, Hosseinpour A, Qorbani M, Daneshzad E.
Front Endocrinol (Lausanne). 2023 Feb 16;14:1087614. doi: 10.3389/fendo.2023.1087614. eCollection 2023.
[Drug allergy].
Yamaguchi M, Akiko K.
Nihon Rinsho. 2005 May;63 Suppl 5:151-5.
Anaphylaxis.
Stroh JE Sr.
J Asthma Res. 1972 Sep;10(1):61-4. doi: 10.3109/02770907209108764.
Allergy to aminophylline.
[No authors listed]
Lancet. 1984 Nov 24;2(8413):1192.
Urticarial reaction to ethylenediamine in an aminophylline compound used for mesotherapy.
Veraldi S, Spigariolo CB.
Contact Dermatitis. 2021 Jan;84(1):59-60. doi: 10.1111/cod.13676. Epub 2020 Aug 24.
